RU2003138080A - Фармацевтическая композиция с антигиперлипидемической активностью - Google Patents

Фармацевтическая композиция с антигиперлипидемической активностью Download PDF

Info

Publication number
RU2003138080A
RU2003138080A RU2003138080/15A RU2003138080A RU2003138080A RU 2003138080 A RU2003138080 A RU 2003138080A RU 2003138080/15 A RU2003138080/15 A RU 2003138080/15A RU 2003138080 A RU2003138080 A RU 2003138080A RU 2003138080 A RU2003138080 A RU 2003138080A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
antihyperlipidemic activity
obesity
antihyperlipidemic
activity
Prior art date
Application number
RU2003138080/15A
Other languages
English (en)
Other versions
RU2292891C2 (ru
Inventor
Клаус МЮНТЕР (DE)
Клаус МЮНТЕР
Михаэль КИРХЕНГАСТ (DE)
Михаэль КИРХЕНГАСТ
Original Assignee
ЭББОТТ ГмбХ унд Ко. КГ (DE)
Эбботт Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭББОТТ ГмбХ унд Ко. КГ (DE), Эбботт Гмбх Унд Ко. Кг filed Critical ЭББОТТ ГмбХ унд Ко. КГ (DE)
Publication of RU2003138080A publication Critical patent/RU2003138080A/ru
Application granted granted Critical
Publication of RU2292891C2 publication Critical patent/RU2292891C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (1)

  1. Фармацевтическая композиция с антигиперлипидемической активностью, содержащая активное вещество, отличающаяся тем, что в качестве активного вещества содержит соединение общей формулы (I)
    Figure 00000001
    где R означает метокси и R1 означает метил или метокси
    или
    R означает метил или группу
    Figure 00000002
    и R1 означает метил.
RU2003138080/15A 1997-12-05 2003-12-29 Фармацевтическая композиция с антигиперлипидемической активностью RU2292891C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754082.1 1997-12-05
DE19754082A DE19754082A1 (de) 1997-12-05 1997-12-05 Methode zur Bekämpfung der Fettleibigkeit

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2000117857/14A Division RU2000117857A (ru) 1997-12-05 1998-11-21 Способ борьбы с ожирением

Publications (2)

Publication Number Publication Date
RU2003138080A true RU2003138080A (ru) 2005-06-10
RU2292891C2 RU2292891C2 (ru) 2007-02-10

Family

ID=7850913

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003138080/15A RU2292891C2 (ru) 1997-12-05 2003-12-29 Фармацевтическая композиция с антигиперлипидемической активностью

Country Status (16)

Country Link
US (1) US6197780B1 (ru)
EP (1) EP1035851B1 (ru)
JP (1) JP2002512173A (ru)
KR (1) KR20010032779A (ru)
CN (1) CN1152685C (ru)
AT (1) ATE204172T1 (ru)
AU (1) AU751053B2 (ru)
BR (1) BR9815335A (ru)
CA (1) CA2311423C (ru)
CZ (1) CZ300442B6 (ru)
DE (2) DE19754082A1 (ru)
ES (1) ES2162493T3 (ru)
HU (1) HUP0100171A3 (ru)
NO (2) NO324694B1 (ru)
RU (1) RU2292891C2 (ru)
WO (1) WO1999029308A2 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
EP2545920A1 (en) 2007-08-22 2013-01-16 Abbott GmbH & Co. KG Therapy for complications of diabetes
ES2665580T3 (es) 2011-11-11 2018-04-26 Gilead Apollo, Llc Inhibidores de ACC y usos de los mismos
WO2016099233A2 (ru) * 2014-10-20 2016-06-23 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
AU2016359626A1 (en) 2015-11-25 2018-05-17 Gilead Apollo, Llc Fungicidal compositions containing derivatives of 2,4-dioxo-1,4-dihydrothieno(2,3-d)pyrimidine
EA201890949A1 (ru) 2015-11-25 2018-12-28 Джилид Аполло, Ллс СЛОЖНОЭФИРНЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
EA201890913A1 (ru) 2015-11-25 2018-11-30 Джилид Аполло, Ллс Пиразоловые соединения в качестве ингибиторов акк и их применение
KR20180082557A (ko) 2015-11-25 2018-07-18 길리어드 아폴로, 엘엘씨 트리아졸 acc 억제제 및 그의 용도
BR112018067408A2 (pt) 2016-03-02 2018-12-26 Gilead Apollo Llc formas sólidas de um inibidor de acc de tienopirimidinadiona e métodos para a produção das mesmas
CN110461328A (zh) 2017-03-28 2019-11-15 吉利德科学公司 治疗肝疾病的治疗组合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658924A (en) 1992-12-01 1997-08-19 The Green Cross Corporation 1,8-naphthyridin-2-one derivative and use thereof
AU6603996A (en) * 1995-08-24 1997-03-19 Warner-Lambert Company Furanone endothelin antagonists
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
KR20010032779A (ko) 2001-04-25
HK1037141A1 (en) 2002-02-01
US6197780B1 (en) 2001-03-06
CN1152685C (zh) 2004-06-09
CZ300442B6 (cs) 2009-05-20
DE59801230D1 (de) 2001-09-20
BR9815335A (pt) 2000-10-17
NO324694B1 (no) 2007-12-03
AU2153599A (en) 1999-06-28
DE19754082A1 (de) 1999-06-10
NO20002777D0 (no) 2000-05-30
CA2311423A1 (en) 1999-06-17
EP1035851B1 (de) 2001-08-16
HUP0100171A3 (en) 2003-10-28
EP1035851A2 (de) 2000-09-20
AU751053B2 (en) 2002-08-08
NO20002777L (no) 2000-06-02
JP2002512173A (ja) 2002-04-23
RU2292891C2 (ru) 2007-02-10
WO1999029308A3 (de) 1999-09-30
NO20074419L (no) 2000-06-02
CN1301162A (zh) 2001-06-27
ATE204172T1 (de) 2001-09-15
CA2311423C (en) 2008-01-29
HUP0100171A2 (hu) 2003-02-28
ES2162493T3 (es) 2001-12-16
WO1999029308A2 (de) 1999-06-17
CZ20002006A3 (cs) 2000-11-15

Similar Documents

Publication Publication Date Title
RU2214418C2 (ru) Аналоги glp-1
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
ATE342922T1 (de) Immobilisierung von proteinen mit hilfe eines polypeptidsegments
EA200200261A1 (ru) Рецептор baff (bcma), иммунорегуляторный агент
DE3881668D1 (de) Piezoelektrische vibrator-pumpe.
EA199800733A1 (ru) Антагонисты рецептора il-8
RU97118224A (ru) Соединения и композиции для доставки активных агентов
RU95108590A (ru) Производные имидазола
IT8847693A0 (it) Fenil carbammato farmacologicamente attivo, suo procedimento di preparazione e composizione farmaceutica che lo contiene
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
DK0733626T3 (da) N-(Benzofurazanyl)-arylsulfonamider og analoger deraf, der kan anvendes som endothelin-receptor-antagonister
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
FI872819L (fi) Vibratorplatta.
DE3774858D1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren.
DE69728914D1 (de) Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen
TR200103680T2 (tr) IL-8 reseptör antagonistleri.
NO20002777D0 (no) FremgangsmÕte for bekjempelse av fedme
TR199901761T2 (xx) IL-8 resept�r antagonistleri.
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
BR9800913A (pt) Promotor de gene cdc25b, preparação e uso do mesmo.
ITTO960496A0 (it) Modificatione di farmaci polipeptidici per accrescere il flusso per e-lettrotrasporto.
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
DE3880226D1 (de) Derivate von calcitonin verwandten gen-peptiden.
DE50011068D1 (de) Fragmente des virus proteins 2 oder 3 des polyomavirus als fähren für wirkstoffe

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20141122